Research/art/teacher profile of a person
Name and surname:
prof. MUDr. Matej Samoš, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Samoš
I.2 - Name
Matej
I.3 - Degrees
Prof. M.D. PhD.
I.4 - Year of birth
1986
I.5 - Name of the workplace
Department of Internal Medicine I, Jessenius Faculty of Medicine in Martin, CU in Bratislava
I.6 - Address of the workplace
Kollárova 2, 036 59 Martin
I.7 - Position
Professor
I.8 - E-mail address
matej.samos@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/17988?mode=full&do=filterForm-submit&university=701000000
I.10 - Name of the study field in which a person works at the university
General Medicine
I.11 - ORCID iD
0000-0002-5561-2560

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava
II.b - Year
2011
II.c - Study field and programme
General Medicine
II.3 - Third degree of higher education
II.a - Name of the university or institution
Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava
II.b - Year
2015
II.c - Study field and programme
Internal Medicine (PhD)
II.4 - Associate professor
II.a - Name of the university or institution
Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava
II.b - Year
2019
II.c - Study field and programme
Internal Medicine (Assoc. Prof.)
II.5 - Professor
II.a - Name of the university or institution
Jesseniova lekárska fakulta v Martine, Univerzita Komenského v Bratislave
II.b - Year
2023
II.c - Study field and programme
Intrnal Medicine (POrof.)
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Professor Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava 2022 -
Associate Professor Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava 2019 - 2022
Assistant Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava 2015 - 2019
Internal PhD. Student Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava 2011 - 2015

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Specialisation in Internal Medicine Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava 2018
Scientific Qualification IIa Slovac Academy of Sciences in Bratislava 2021
Specialisation in Cardiology Faculty of Medicine, P.J. Šafárik University in Košice 2021

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Propedeutics of Internal Medicine 1,2 General Medicine I.+II. General Medicine
Internal Medicine 1 - 5 General Medicine I.+II. General Medicine
Propedeutics of Internal Medicine Dentistry, Dental Medicine I.+II. Dentistry, Dental Medicine
Internal Medicine 1 - 4 Dentistry I.+II. Dentistry, Dental Medicine
Internal Medicine 1,2 Internal Medicine III. General Medicine
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.b - Diploma (second degree)
4
V.4.c - Dissertation (third degree)
5
V.4.2 - Number of defended theses
V.4.b - Diploma (second degree)
11
V.4.c - Dissertation (third degree)
4
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
Diploma Thesis Semminar 1-3 General Medicine I.+II. General Medicine

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
257
VI.1.b - Over the last six years
135
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
74
VI.1.b - Over the last six years
48
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
166
VI.1.b - Over the last six years
155
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
155
VI.1.b - Over the last six years
150
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
25
VI.1.b - Over the last six years
20
VI.2 - The most significant research/artistic/other outputs
1

Samoš M, Šimonová R, Kovář F, Duraj L, Fedorová J, Galajda P, Staško J, Fedor M, Kubisz P, Mokáň M. Clopidogrel resistance in diabetic patient with acute myocardial infarction due to stent thrombosis. Am J Emerg Med 2014; 32: 461 - 465.



2

Samoš M, Stančiaková L, Ivanková J, Staško J, Kovář F, Dobrotová M, Galajda P, Kubisz P, Mokáň M. Monitoring of dabigatran therapy using Hemoclot(®) Thrombin Inhibitor assay in patients with atrial fibrillation. J Thromb Thrombolysis 2015; 39: 95 - 100.


3

Samoš M, Bolek T, Ivanková J, Stančiaková L, Kovář F, Galajda P, Kubisz P, Staško J, Mokáň M. Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences. J Cardiovasc Pharmacol 2016; 68: 391 - 394.


4

Bolek T, Samoš M, Stančiaková L, Ivanková J, Škorňová I, Staško J, Galajda P, Kubisz P, Mokáň M. The Impact of Proton Pump Inhibition on Dabigatran Levels in Patients With Atrial Fibrillation. Am J Ther 2019; 26: e308 - e313.

5

Samoš M, Bolek T, Stančiaková L, Škorňová I, Ivanková J, Kovář F, Galajda P, Kubisz P, Staško J, Mokáň M. Does type 2 diabetes affect the on-treatment levels of direct oral anticoagulants in patients with atrial fibrillation? Diabetes Res Clin Pract 2018; 135: 172 - 177.


VI.3 - The most significant research/artistic/other outputs over the last six years
1

Samoš M, Bolek T, Ivanková J, Stančiaková L, Kovář F, Galajda P, Kubisz P, Staško J, Mokáň M. Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences. J Cardiovasc Pharmacol 2016; 68: 391 - 394.


2

Bolek T, Samoš M, Stančiaková L, Ivanková J, Škorňová I, Staško J, Galajda P, Kubisz P, Mokáň M. The Impact of Proton Pump Inhibition on Dabigatran Levels in Patients With Atrial Fibrillation. Am J Ther 2019; 26: e308 - e313.

3

Samoš M, Bolek T, Stančiaková L, Škorňová I, Ivanková J, Kovář F, Galajda P, Kubisz P, Staško J, Mokáň M. Does type 2 diabetes affect the on-treatment levels of direct oral anticoagulants in patients with atrial fibrillation? Diabetes Res Clin Pract 2018; 135: 172 - 177.


4

Samoš M, Bolek T, Stančiaková L, Škorňová I, Bánovčin P Jr, Kovář F, Staško J, Galajda P, Kubisz P, Mokáň M. Anti-Xa activity in oral factor Xa inhibitor-treated patients with atrial fibrillation and a higher risk of bleeding: a pilot study. Blood Coagul Fibrinolysis 2018; 29: 369 - 373.


5

Samoš M, Bolek T, Škorňová I, Benko J, Staško J, Kubisz P, Galajda P, Mokán M. Apixaban: a novel agent to treat heparin induced thrombocytopenia and to prevent embolism in patient with atrial fibrillation after multiple valve replacement? J Thromb Thrombolysis 2019; 48: 619 - 622.


VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Chan, N. C. - Coppens, M. - Hirsh, J. - Ginsberg, J. S. - Weitz, J. I. - Vanassche, T. - Douketis, J. D. - Schulman, S. - Eikelboom, J. W.: Journal of Thrombosis and Haemostasis, roč. 13, č. 3, 2015, s. 353-359 - SCI ; SCOPUS

2

Douketis, J. D. - Wang, G. - Chan, N. - Eikelboom, J. W. - Syed, S. - Barty, R. - Moffat, K. A. - Spencer, F. A. - Blostein, M. - Schulman, S.: Journal of Thrombosis and Haemostasis, roč. 14, č. 1, 2016, s. 89-97 - SCI ; SCOPUS

3

Warkentin, T. E. - Pai, M. - Linkins, L. A.: Blood, roč. 130, č. 9, 2017, s. 1104-1113 - SCI ; SCOPUS

4

Wang, N. - Chen, L. - Li, N. - Xu, G. - Qi, F. - Zhu, L. - Liu, W.: Scientific Reports, roč. 10, č. 1, 2020, čl. č. 9717 - SCI ; SCOPUS

5

Shin, H. J. - Boo, G. - Na, H. S.: Journal of Anesthesia, roč. 35, č. 5, 2021, s. 633-637 - SCI ; SCOPUS

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

APVV 16-00-20 Specific laboratory monitoring of platelets reactivity in patients with acute myocardial infarction treated by new antagonists of P2Y12 receptors  (Co-Investigator).

2

VEGA 1/0549/19 Applications of results of DNA analyse and microRNA detection in primary and secondary proplylaxis of thromboembolic complications in patients with sticky platelet syndrome  (Co-Investigator).

3

VEGA 1/0090/20 (2020 – 2022) New trends in treatment and new markers of progression of chronic heart disease with preserved ejection function im patients with type 2 diabetes mellitus. Research of risk factors of chronic heart failure with preserved ejection fraction in patients with obesity and type 2 diabetes mellitus. (Principal Investigator).

4

ITMS 2014+: 313011V344 European Structural and Investment Funds Long-term strategic research of prevention, intervention and mechanisms of obesity and its comorbidities. Activity – Mechanisms and markers of obesity and its comorbidities – research of microRNA as biomarkers. (Co-investigator).

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position VII.b - Name of the institution, board VII.c - Duration
Editorial Board Member Frontiers in Endocrinology 2020 -
Editorial Board Member Forum Diabetologicum 2022 -
Member of Academy of Postgraduate Education European Federation of Internal Medicine (EFIM) 2021 -
Editorial Board Member American Journal of Therapeutics 2023 -
Guest Editor Pharmaceuticals 2023 -

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

IX.a - If relevant, other activities related to higher education or research/artistic/other activities are mentioned

Expert in Internal Medicine and Cardiology

Date of last update
2025-02-20